InspireMD Inc Share Price Nyse
Equities
US45779A3095
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
14/05 | Transcript : InspireMD, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.5M, vs. Street Est of $1.9M | MT |
Sales 2024 * | 7.09M 592M | Sales 2025 * | 14.65M 1.22B | Capitalization | 53.88M 4.5B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 7.59 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.68 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.51% |
Latest transcript on InspireMD Inc
Managers | Title | Age | Since |
---|---|---|---|
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01/20/01 |
Craig Shore
DFI | Director of Finance/CFO | 62 | 31/11/31 |
Juan Rigla
CTO | Chief Tech/Sci/R&D Officer | - | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Roubin
BRD | Director/Board Member | 75 | 13/20/13 |
Marvin Slosman
CEO | Chief Executive Officer | 60 | 01/20/01 |
Thomas Kester
BRD | Director/Board Member | 77 | 06/16/06 |
1st Jan change | Capi. | |
---|---|---|
-4.72% | 182B | |
+3.96% | 112B | |
-2.93% | 68.58B | |
+6.30% | 51.58B | |
+8.02% | 44.24B | |
+7.74% | 43.65B | |
+26.18% | 32.46B | |
+18.56% | 25.99B | |
+0.57% | 25.61B |